AR-42
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for AR-42, covering 2018-03-14 to 2022-05-11. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma [EARLY_Phase 1]